Bullish Moving Averages
3
Bearish Moving Averages
13
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
170.50Today’s High
174.5052W low
133.0052W High
283.00Open Price
172.20Prev. Close
144.9500Volume
494197.00Value
85179794.92Fundamentals
Market Cap
2702.30
Price to Earnings
-17.60
Price to Book Value
0.50
Dividend Yield
0.00
PE to Growth
0.00
Op Revenue TTM
2615.77
Net Profit TTM
-153.45
Cash From Operating Activity
383.97
Return on Equity %
-2.72
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
05 Jul, 2024
55.7
Week
50.1
Month
44.3
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
172.45
PIVOT
First Resistance
174.41
Second Resistance
176.45
Third Resistance
178.41
First Support
170.41
Second Support
168.45
Third Support
166.41
Relative Strength Index
46.97
Money Flow Index
57.41
MACD
-2.79
MACD Signal
-4.21
Average True Range
7.88
Average Directional Index
22.13
Rate of Change (21)
15.21
Rate of Change (125)
-10.35
Commodity Channel Index
16.1
Williams %R
-66.5
BETA
1 Month
2.47
3 Month
1.66
1 Year
1.3
3 Year
0.52
PRICE CHANGE ANALYSIS
↓ -3.55%
1 Week
Low
High
168.61
181.01
↑ 18.91%
1 Month
Low
High
145.15
184.8
↓ -30.11%
3 Months
Low
High
133
253.85
↓ -7.73%
6 Months
Low
High
133
283
↑ 21.12%
1 Year
Low
High
133
283
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 108.05 | 99.93 | 98.43 | 83.99 | 127.92 | 90.76 | 127.42 | 108.61 | 96.64 | 89.82 | 101.38 | |
| Operating Expenses Qtr | 99.69 | 83.65 | 62.64 | 74.57 | 106.78 | 81.60 | 105.39 | 101.05 | 82.12 | 69.11 | 59.23 | |
| Operating Profit Qtr | 11.57 | 3.17 | -2.92 | -5.02 | 6.35 | -3.20 | 1.15 | 2.56 | 1.22 | 3.82 | 24.92 | |
| EBIDT Qtr Cr | 8.36 | 16.28 | 32.74 | 9.42 | 21.14 | 7.16 | 22.03 | 7.56 | 11.11 | 20.71 | 39.65 | |
| Depreciation Qtr | 26.12 | 26.22 | 24.58 | 24.69 | 23.45 | 2.89 | 35.20 | 34.65 | 34.49 | 35.41 | 35.74 | |
| Net Profit Qtr | -31.12 | -18.18 | -5.78 | -21.33 | -10.23 | -6.54 | -17.28 | -24.83 | 4.83 | -19.63 | -2.81 | |
| Basic EPS Qtr | -1.98 | -1.16 | -0.37 | -1.36 | -0.65 | -0.42 | -1.10 | -1.58 | 0.31 | -1.25 | -0.18 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 390.40 | 454.71 | 368.50 | 266.47 | 650.29 | |
| Operating Expenses Annual Cr | 320.55 | 394.79 | 268.60 | 252.97 | 407.16 | |
| Operating Profit Annual | 6.80 | 7.76 | 34.19 | -52.65 | 173.58 | |
| Operating Profit Margin Annual % | 1.74 | 1.71 | 9.28 | -19.76 | 26.69 | |
| Total Expenses Annual Cr | 490.35 | 548.91 | 445.90 | 428.49 | 594.83 | |
| EBIDT Annual Cr | 69.85 | 59.92 | 99.90 | 13.50 | 243.13 | |
| EBIDT Annual margin % | 17.89 | 13.18 | 27.11 | 5.07 | 37.39 | |
| Depreciation | 101.61 | 96.20 | 140.07 | 141.35 | 140.65 | |
| PAT Before ExtraOrdinary Items Annual Cr | -76.41 | -58.87 | -30.47 | -226.14 | 38.52 | |
| Net Profit Annual | -76.41 | -58.87 | -31.55 | -232.81 | 38.52 | |
| Basic EPS Annual | -4.87 | -3.75 | -2.01 | -14.85 | 2.46 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 4052.58 | 4114.31 | 4231.78 | 4674.62 | 4795.85 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 405.35 | 425.13 | 431.34 | 346.25 | 318.38 | |
| Total Current Liabilities Annual Cr | 618.73 | 641.60 | 551.19 | 530.88 | 620.45 | |
| Total Capital Plus Liabilities Annual Cr | 5076.66 | 5181.04 | 5214.31 | 5551.75 | 5734.68 | |
| Fixed Assets Annual | 1473.74 | 1525.19 | 1473.75 | 1630.85 | 1721.37 | |
| Total Non Current Assets Annual | 4489.44 | 4531.43 | 4448.52 | 4828.69 | 4969.97 | |
| Total Current Assets Annual | 587.22 | 649.61 | 765.79 | 723.06 | 764.71 | |
| Total Assets Annual | 5076.66 | 5181.04 | 5214.31 | 5551.75 | 5734.68 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 642.28 | 625.19 | 395.92 | 467.50 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 24.17 | -52.90 | 227.35 | -1.51 | 196.70 | |
| Cash from Investing Activity Annual | 96.57 | 40.71 | -172.67 | 62.07 | -74.30 | |
| Cash from Financing Annual Activity | -130.76 | 1.38 | -46.16 | -70.53 | -124.07 | |
| Net Cash Flow Annual | - | -10.81 | 8.52 | -9.97 | -1.67 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 258.46 | 262.39 | 269.88 | 298.13 | 305.66 | |
| ROE Annual % | -1.88 | -1.43 | -0.74 | -4.98 | 0.80 | |
| ROCE Annual % | -0.71 | -0.79 | -0.86 | -2.54 | 2.00 | |
| Total Debt to Total Equity Annual | 0.13 | 0.14 | 0.12 | 0.11 | 0.10 | |
| EBDIT Annual Margin % | 21.33 | 14.88 | 32.99 | 6.73 | 41.86 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 661.87 | 657.14 | 595.06 | 729.91 | 625.31 | 646.29 | 622.81 | 546.28 | 573.36 | 581.12 | 468.50 | |
| Operating Expenses Qtr | 592.03 | 609.98 | 525.74 | 601.52 | 567.12 | 525.92 | 535.36 | 452.32 | 547.00 | 452.58 | 359.67 | |
| Operating Profit Qtr | 62.68 | 41.11 | 60.85 | 121.86 | 51.44 | 113.87 | 78.60 | 88.29 | 21.99 | 109.50 | 99.23 | |
| EBIDT Qtr Cr | 66.75 | 47.16 | 66.27 | 128.39 | 12.57 | 117.84 | 87.45 | 93.96 | 14.22 | 128.54 | 106.33 | |
| Depreciation Qtr | 85.00 | 80.37 | 75.04 | 70.45 | 75.74 | 50.33 | 79.57 | 75.08 | 83.88 | 74.95 | 74.05 | |
| Net Profit Qtr | -69.92 | -59.63 | -40.90 | 17.00 | -70.72 | 46.96 | -10.05 | 4.01 | -44.62 | 35.38 | 11.19 | |
| Basic EPS Qtr | -4.46 | -3.80 | -2.61 | 1.08 | -4.51 | 3.00 | -0.64 | 0.26 | -2.85 | 2.26 | 0.71 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 2643.98 | 2440.69 | 2184.11 | 1950.48 | 2088.06 | |
| Operating Expenses Annual Cr | 2329.27 | 2080.72 | 1809.32 | 1637.68 | 1546.04 | |
| Operating Profit Annual | 286.50 | 332.20 | 331.37 | 274.35 | 497.56 | |
| Operating Profit Margin Annual % | 10.84 | 13.61 | 15.17 | 14.07 | 23.83 | |
| Total Expenses Annual Cr | 2760.10 | 2447.13 | 2173.72 | 1993.23 | 1890.86 | |
| EBIDT Annual Cr | 314.71 | 359.97 | 374.79 | 312.80 | 542.02 | |
| EBIDT Annual margin % | 11.90 | 14.75 | 17.16 | 16.04 | 25.96 | |
| Depreciation | 310.86 | 280.72 | 307.59 | 307.94 | 282.87 | |
| PAT Before ExtraOrdinary Items Annual Cr | -153.45 | -29.80 | 18.01 | -165.13 | 158.51 | |
| Net Profit Annual | -153.45 | -29.80 | 18.01 | -165.13 | 158.51 | |
| Basic EPS Annual | -9.79 | -1.90 | 1.15 | -10.53 | 10.10 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 5627.50 | 5809.67 | 5548.94 | 5698.82 | 5715.06 | |
| Minority Interest Liability Annual Cr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non Current Liabilities Annual Cr | 1399.19 | 1845.44 | 1668.72 | 1376.98 | 915.80 | |
| Total Current Liabilities Annual Cr | 2554.72 | 1798.39 | 1419.79 | 1248.80 | 1568.95 | |
| Total Capital Plus Liabilities Annual Cr | 9581.41 | 9453.50 | 8637.45 | 8324.60 | 8199.81 | |
| Fixed Assets Annual | 3187.38 | 3367.22 | 2906.53 | 2603.05 | 2227.38 | |
| Total Non Current Assets Annual | 7653.22 | 7535.14 | 6798.73 | 6661.96 | 6420.84 | |
| Total Current Assets Annual | 1928.19 | 1918.36 | 1838.72 | 1662.64 | 1778.97 | |
| Total Assets Annual | 9581.41 | 9453.50 | 8637.45 | 8324.60 | 8199.81 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 675.78 | 758.07 | 932.53 | 648.03 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 383.97 | 220.34 | 354.85 | 513.43 | 585.14 | |
| Cash from Investing Activity Annual | -229.52 | -448.46 | -618.53 | -380.79 | -441.74 | |
| Cash from Financing Annual Activity | -22.15 | 249.67 | 130.37 | -11.04 | -97.78 | |
| Net Cash Flow Annual | - | 21.55 | -133.31 | 121.60 | 45.62 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 358.90 | 370.51 | 353.89 | 363.44 | 364.25 | |
| ROE Annual % | -2.72 | -0.51 | 0.32 | -2.89 | 2.77 | |
| ROCE Annual % | 0.05 | 1.03 | 0.93 | 0.06 | 3.90 | |
| Total Debt to Total Equity Annual | 0.35 | 0.31 | 0.26 | 0.18 | 0.16 | |
| EBDIT Annual Margin % | 12.03 | 14.91 | 17.50 | 16.35 | 26.52 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Massachusetts Institute Of Technology | 1.95 | 75074220 | - | - |
| Mukul Mahavir Agrawal | 5.74 | 75074232 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Adimans Technologies LLP | 59.32 | 75074190 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| Quant Mutual Fund - Quant Value Fund | 1.16 | 75074216 |
| Hbm Healthcare Investments (Cayman) Ltd | 3.55 | 75074222 |
| Massachusetts Institute Of Technology | 1.95 | 75074220 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| Mukul Mahavir Agrawal | 5.74 | 75074232 |
| HUF | 0.81 | 75074224 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Sep 12, 2019 | 0.2 | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 30, 2024 | Audited Results | - |
| Feb 14, 2024 | Quarterly Results | - |
| Nov 08, 2023 | Quarterly Results | - |
| Aug 09, 2023 | Quarterly Results | - |
| May 23, 2023 | Audited Results | - |
| Feb 10, 2023 | Quarterly Results | - |
| Jan 17, 2023 | Others | Inter alia, to consider and approve the proposal of fund raising by way of issuance of Non-Convertible Debentures, by way of private placement. |
| Nov 11, 2022 | Quarterly Results | - |
| Aug 09, 2022 | Quarterly Results | - |
| May 10, 2022 | Audited Results | - |
| Feb 03, 2022 | Quarterly Results | - |
| Oct 28, 2021 | Quarterly Results | - |
| Aug 12, 2021 | Quarterly Results | - |
| Jun 16, 2021 | Employees Stock Option Plan | - |
| May 11, 2021 | Audited Results | - |
| Feb 11, 2021 | Quarterly Results | - |
| Nov 12, 2020 | Quarterly Results | - |
| Sep 08, 2020 | Audited Results | (Revised) |
| Jun 03, 2020 | Audited Results | - |
| Jan 23, 2020 | Quarterly Results | - |
| Jan 16, 2020 | Buy Back of Shares & ESOP | - |
| Oct 23, 2019 | Quarterly Results | - |
| Aug 13, 2019 | Quarterly Results | - |
| May 15, 2019 | Audited Results & Final Dividend | (Revised) |
| May 08, 2019 | Audited Results & Final Dividend | - |
| Jan 23, 2019 | Quarterly Results | - |
| Nov 01, 2018 | Quarterly Results | - |
| Jul 25, 2018 | Quarterly Results | - |
| May 16, 2018 | Audited Results | - |
| Jan 24, 2018 | Quarterly Results | - |
| Nov 09, 2017 | Quarterly Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
05 Jul 2024
Dishman Carbogen Amcis Ltd - 540701 - Compliance-57 (5) : intimation after the end of quarter
Please find attached herewith Intimation under Regulation 57(5) of SEBI (LODR) Regulations, 2015.
27 Jun 2024
Dishman Carbogen Amcis Ltd - 540701 - Disclosure Pursuant To Regulation 30 Of SEBI (LODR) Regulations, 2015: The Company'S Wholly Owned Subsidiary, CARBOGEN AMCIS AG Successfully Completed US FDA Inspection Of Its Manufacturing Sites Located In Hunzenschwil (Neuland), Switzerland And Aarau, Switzerland
Please find attached herewith Disclosure pursuant to Regulation 30 of SEBI(LODR) Regulations, 2015 regarding successful completion of US FDA Inspection at Company''s Wholly owned subsidiary.
27 Jun 2024
Dishman Carbogen Amcis Ltd - 540701 - Closure of Trading Window
Please find attached herewith Intimation of Closure of Trading Window for the Quarter ending 30th June, 2024.
13 Jun 2024
Dishman Carbogen Amcis Ltd - 540701 - DISCLOSURE UNDER REGULATIONS 30 OF SEBI (LODR) REGULATIONS, 2015: INTIMATION OF CHANGE IN SENIOR MANAGEMENT PERSONNEL
Pls. find enclosed herewith the intimation of Change in Senior Management Personnel of the Company.
07 Jun 2024
Dishman Carbogen Amcis Ltd - 540701 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Pls. find attached herewith the Transcript of Conference Call held on 31st May, 2024.
31 May 2024
Dishman Carbogen Amcis Ltd - 540701 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, the audio recording of Conference Call arranged by the Company with Investors on Friday, 31st May, 2024 which was commenced at 12:30 hrs. (IST) to discuss the financial result and performance of the Company for the quarter and year ended on 31st March, 2024 is available on the Company's website at https://imdcal.com/ir-index.php?Investor%20Call%20Recording%20and%20Transcript/Audio-Video%20Recording/2023-24#Q4Result-Audio%20Recording-31.05.2024.mp3
30 May 2024
Dishman Carbogen Amcis Ltd - 540701 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pls. find attached herewith Investor Presentation on Audited Financial Result for the quarter and year ended 31st March, 2024.
30 May 2024
Dishman Carbogen Amcis Ltd - 540701 - Board Meeting Outcome for OUTCOME OF BOARD MEETING ALONGWITH AUDITED FINANCIAL RESULTS ALONGWITH STATUTORY AUDITORS' AUDIT REPORT (STANDALONE AND CONSOLIDATED) FOR THE QUARTER AND YEAR ENDED 31/03/2024
We hereby inform and submit that: 1) the Board of Directors of the Company in their meeting held today i.e. on Thursday, the 30th day of May, 2024 which was commenced at 04:00 P.M. and concluded at 11:15 P.M., inter alia, have approved the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended 31st March, 2024. 2) the said Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended 31st March, 2024 prepared in terms of Regulations 33 and 52 of SEBI (LODR) Regulations, 2015, along with Statutory Auditors' Audit Report with unmodified opinion dated 30th May, 2024 issued by M/s. T R Chadha & Co. LLP, Chartered Accountants are enclosed herewith. and Outcome of Board Meeting mentioned in attached file.
30 May 2024
Dishman Carbogen Amcis Ltd - 540701 - OUTCOME OF BOARD MEETING ALONGWITH AUDITED FINANCIAL RESULTS ALONGWITH STATUTORY AUDITORS' AUDIT REPORT (STANDALONE AND CONSOLIDATED) FOR THE QUARTER AND YEAR ENDED 31/03/2024
Pls. find attached herewith the Audited Financial Result for the year ended 31st March, 2024 along with Auditors Report and Outcome of Board Meeting.
30 May 2024
Dishman Carbogen Amcis Ltd - 540701 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Please find attached herewith the Annual Secretarial Compliance Report for the year ended on March 31, 2024.
